Chromosome 9p deletions identify an aggressive phenotype of clear cell renal cell carcinoma

Cancer

Volumn 116, Issue 20, 2010, Pages 4696-4702

  La Rochelle, Jeffrey ^a   Klatte, Tobias ^a   Dastane, Aditi ^a   Rao, Nagesh ^a   Seligson, David ^a   Said, Jonathan ^a   Shuch, Brian ^a   Zomorodian, Nazy ^a   Kabbinavar, Fairooz ^a   Belldegrun, Arie ^a   Pantuck, Allan J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Biomarkers; Chromosome 9p; Kidney cancer; Prognosis; Renal cell carcinoma

Indexed keywords

ARTICLE; CANCER CLASSIFICATION; CANCER GRADING; CANCER STAGING; CHROMOSOME 9P; CHROMOSOME DELETION; CONTROLLED STUDY; CYTOGENETICS; DISEASE SPECIFIC SURVIVAL; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE FREE SURVIVAL; CHROMOSOME 9; DISEASE FREE SURVIVAL; GENETICS; KIDNEY TUMOR; METASTASIS; MORTALITY; PATHOLOGY;

CARCINOMA, RENAL CELL; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 9; DISEASE-FREE SURVIVAL; HUMANS; KIDNEY NEOPLASMS; LYMPHATIC METASTASIS; NEOPLASM METASTASIS;

EID: 78349258143     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25279     Document Type: Article

References (16)

1. Hollingsworth JM, Miller DC, Daignault S, Hollenbeck BK. Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst. 2006;98:1331-1334. (Pubitemid 44530728)
2. Chawla SN, Crispen PL, Hanlon AL, Greenberg RE, Chen DY, Uzzo RG. The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol. 2006;175:425-431. (Pubitemid 43067318)
3. Klatte T, Patard JJ, de Martino M, et al. Tumor size does not predict risk of metastatic disease or prognosis of small renal cell carcinomas. J Urol. 2008;179:1719-1726.
4. Volpe A, Kachura JR, Geddie WR, et al. Techniques, safety and accuracy of sampling of renal tumors by fine needle aspiration and core biopsy. J Urol. 2007;178:379-386. (Pubitemid 47030509)
5. Patard JJ, Fergelot P, Karakiewicz PI, et al. Low CAIX expression and absence of VHL gene mutation are associated with tumor aggressiveness and poor survival of clear cell renal cell carcinoma (RCC). Int J Cancer. 2008;123:395-400. (Pubitemid 351842025)
6. Yao M, Yoshida M, Kishida T, et al. VHL tumor suppressor gene alterations associated with good prognosis in sporadic clear-cell renal carcinoma. J Natl Cancer Inst. 2002;94:1569-1575. (Pubitemid 35277281)
7. Klatte T, Rao PN, de Martino M, et al. Cytogenetic profile predicts prognosis of patients with clear cell renal cell carcinoma. J Clin Oncol. 2009;27:746-753.
8. Presti JC, Wilhelm M, Reuter V, Russo P, Motzer R, Waldman F. Allelic loss on chromosomes 8 and 9 correlates with clinical outcome in locally advanced clear cell carcinoma of the kidney. J Urol. 2002;167:1464-1468. (Pubitemid 34132133)
9. Schullerus D, Herbers J, Chudek J, Kanamaru H, Kovacs G. Loss of heterozygosity at chromosomes 8p, 9p, and 14q is associated with stage and grade of non-papillary renal cell carcinomas. J Pathol. 1997;183:151-155. (Pubitemid 27436017)
10. Brunelli M, Eccher A, Gobbo S, et al. Loss of chromosome 9p is an independent prognostic factor in patients with clear cell renal cell carcinoma. Mod Pathol. 2008;21:1-6.
11. Cairns P, Tokino K, Eby Y, Sidransky D. Localization of tumor suppressor loci on chromosome 9 in primary human renal cell carcinomas. Cancer Res. 1995;55:224-227.
12. Jaeger E, Waldmann F, Roydasgupta R, et al. Array-based comparative genomic hybridization (CGH) identifies chromosomal imbalances between interleukin-2 complete and non-responders [abstract]. J Clin Oncol. 2008;26(May 20 suppl). Abstract 5043.
13. Klatte T, Lam JS, Shuch B, Belldegrun AS, Pantuck AJ. Surveillance for renal cell carcinoma: why and how? When and how often? Urol Oncol. 2008;26:550-554.
14. Kinkle DA, Crispen PL, Chen DYT, Greenberg RE, Uzzo RG. Enhancing renal masses with zero net growth during active surveillance. J Urol. 2007;177:849-854. (Pubitemid 46216338)
15. Bui MH, Seligson D, Han KR, et al. Carbonic anhydrase IX is an independent predictor of survival in advanced renal cell carcinoma: implications for prognosis and therapy. Clin Cancer Res. 2003;9:802-811. (Pubitemid 36182618)
16. Atkins M, Regan M, McDermott D, et al. Carbonic anhydrase IX expression predicts outcome of interleukin-2 therapy for renal cancer. Clin Cancer Res. 2005;11:3714-3721. (Pubitemid 40685588)